7V91 Stock Overview
Provides healthcare technology and services in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Visiomed Group SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.22 |
| 52 Week High | €0.51 |
| 52 Week Low | €0.22 |
| Beta | -0.50 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -49.72% |
| 5 Year Change | n/a |
| Change since IPO | -87.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7V91 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.0% | 1.6% |
| 1Y | n/a | -0.6% | 7.3% |
Return vs Industry: Insufficient data to determine how 7V91 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 7V91 performed against the German Market.
Price Volatility
| 7V91 volatility | |
|---|---|
| 7V91 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7V91 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 7V91's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 73 | Clement Pacaud | www.visiomed.fr |
Visiomed Group SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. Visiomed Group SA was founded in 2007 and is headquartered in Paris, France.
Visiomed Group SA Fundamentals Summary
| 7V91 fundamental statistics | |
|---|---|
| Market cap | €57.85m |
| Earnings (TTM) | -€3.54m |
| Revenue (TTM) | €12.04m |
4.8x
P/S Ratio-16.3x
P/E RatioIs 7V91 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7V91 income statement (TTM) | |
|---|---|
| Revenue | €12.04m |
| Cost of Revenue | €7.28m |
| Gross Profit | €4.76m |
| Other Expenses | €8.30m |
| Earnings | -€3.54m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 39.53% |
| Net Profit Margin | -29.39% |
| Debt/Equity Ratio | 35.7% |
How did 7V91 perform over the long term?
See historical performance and comparison